Achmea Investment Management B.V. Has $61.36 Million Stake in Lam Research Corporation (NASDAQ:LRCX)

Achmea Investment Management B.V. raised its holdings in Lam Research Corporation (NASDAQ:LRCX - Free Report) by 213.2% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 844,023 shares of the semiconductor company's stock after acquiring an additional 574,561 shares during the period. Lam Research comprises about 0.9% of Achmea Investment Management B.V.'s investment portfolio, making the stock its 15th largest holding. Achmea Investment Management B.V. owned about 0.07% of Lam Research worth $61,361,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of LRCX. Fairway Wealth LLC grew its stake in shares of Lam Research by 900.0% in the fourth quarter. Fairway Wealth LLC now owns 340 shares of the semiconductor company's stock valued at $25,000 after buying an additional 306 shares in the last quarter. West Paces Advisors Inc. acquired a new position in Lam Research in the 4th quarter valued at about $27,000. Mpwm Advisory Solutions LLC acquired a new position in shares of Lam Research in the fourth quarter valued at approximately $27,000. Bell Investment Advisors Inc lifted its holdings in Lam Research by 836.6% during the 4th quarter. Bell Investment Advisors Inc now owns 384 shares of the semiconductor company's stock worth $28,000 after purchasing an additional 343 shares during the last quarter. Finally, Avalon Trust Co boosted its stake in Lam Research by 791.3% in the 4th quarter. Avalon Trust Co now owns 410 shares of the semiconductor company's stock valued at $30,000 after purchasing an additional 364 shares during the period. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Lam Research Stock Up 0.9%

Shares of NASDAQ:LRCX opened at $96.84 on Friday. The stock has a market cap of $123.87 billion, a price-to-earnings ratio of 26.99, a PEG ratio of 1.35 and a beta of 1.65. The business's 50 day moving average is $81.92 and its 200 day moving average is $78.07. Lam Research Corporation has a 12-month low of $56.32 and a 12-month high of $113.00. The company has a quick ratio of 1.64, a current ratio of 2.45 and a debt-to-equity ratio of 0.39.

Lam Research (NASDAQ:LRCX - Get Free Report) last posted its earnings results on Wednesday, April 23rd. The semiconductor company reported $1.04 EPS for the quarter, topping the consensus estimate of $1.00 by $0.04. The firm had revenue of $4.72 billion for the quarter, compared to analysts' expectations of $4.64 billion. Lam Research had a net margin of 27.18% and a return on equity of 53.21%. The company's quarterly revenue was up 24.4% compared to the same quarter last year. During the same quarter last year, the firm earned $7.79 EPS. On average, sell-side analysts forecast that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 9th. Shareholders of record on Wednesday, June 18th will be given a $0.23 dividend. This represents a $0.92 annualized dividend and a yield of 0.95%. The ex-dividend date of this dividend is Wednesday, June 18th. Lam Research's dividend payout ratio is 25.63%.

Analyst Upgrades and Downgrades

LRCX has been the topic of several research reports. Oppenheimer restated an "outperform" rating and issued a $110.00 price target (up from $80.00) on shares of Lam Research in a research note on Tuesday, June 17th. Barclays decreased their price target on shares of Lam Research from $75.00 to $70.00 and set an "equal weight" rating on the stock in a report on Tuesday, April 22nd. UBS Group cut their target price on shares of Lam Research from $95.00 to $90.00 and set a "buy" rating on the stock in a research report on Monday, April 14th. Wells Fargo & Company reduced their price objective on Lam Research from $85.00 to $75.00 and set an "equal weight" rating on the stock in a research report on Thursday, April 24th. Finally, B. Riley reaffirmed a "buy" rating and issued a $115.00 price objective (up previously from $95.00) on shares of Lam Research in a research note on Wednesday, June 18th. Seven investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Lam Research currently has a consensus rating of "Moderate Buy" and a consensus target price of $93.97.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.